Egypt's NUCA, SHMFF sign New Cairo land allocation for integrated urban project    CIB named Egypt's Bank of the Year 2025 as factoring portfolio hits EGP 4bn    Egypt declares Red Sea's Great Coral Reef a new marine protected area    Oil prices edge higher on Thursday    Gold prices fall on Thursday    Egypt, Volkswagen discuss multi-stage plan to localise car manufacturing    Egypt denies coordination with Israel over Rafah crossing    Egypt to swap capital gains for stamp duty to boost stock market investment    Egypt tackles waste sector funding gaps, local governance reforms    Egypt, Switzerland explore expanded health cooperation, joint pharmaceutical ventures    Egypt recovers two ancient artefacts from Belgium    Private Egyptian firm Tornex target drones and logistics UAVs at EDEX 2025    Egypt opens COP24 Mediterranean, urges faster transition to sustainable blue economy    Egypt's Abdelatty urges deployment of international stabilisation force in Gaza during Berlin talks    Egypt, Saudi nuclear authorities sign MoU to boost cooperation on nuclear safety    Giza master plan targets major hotel expansion to match Grand Egyptian Museum launch    Australia returns 17 rare ancient Egyptian artefacts    China invites Egypt to join African duty-free export scheme    Egypt calls for stronger Africa-Europe partnership at Luanda summit    Egypt begins 2nd round of parliamentary elections with 34.6m eligible voters    Egypt warns of erratic Ethiopian dam operations after sharp swings in Blue Nile flows    Egypt scraps parliamentary election results in 19 districts over violations    Egypt extends Ramses II Tokyo Exhibition as it draws 350k visitors to date    Egypt signs host agreement for Barcelona Convention COP24 in December    Al-Sisi urges probe into election events, says vote could be cancelled if necessary    Filmmakers, experts to discuss teen mental health at Cairo festival panel    Cairo International Film Festival to premiere 'Malaga Alley,' honour Khaled El Nabawy    Egypt golf team reclaims Arab standing with silver; Omar Hisham Talaat congratulates team    Egypt launches National Strategy for Rare Diseases at PHDC'25    Egypt launches Red Sea Open to boost tourism, international profile    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Sisi expands national support fund to include diplomats who died on duty    Egypt's PM reviews efforts to remove Nile River encroachments    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



New report says sleeping pills is likely as dangerous as smoking cigarettes
Published in Amwal Al Ghad on 28 - 02 - 2012

Hundreds of thousands of people who take sleeping pills just twice a month are nearly four times more likely to die prematurely, according to new research.
The study, published in the journal BMJ Open, analyzed 10,500 people taking a wide-range of sleeping pills, including tamazepam and diazepam. They compared people taking sleeping tablets with those who were not using the drugs but had a similar lifestyle and health conditions.
People taking higher doses of tamazepam pills, which were dispensed 2.8m times in England in 2010, were six times more likely to die in the next two-and-a-half years.
For the drug zolpidem, which was prescribed 733,000 times in England in 2010, the risk of death was 5.7 times higher for those taking them most frequently.
The drug zopiclone, which was prescribed 5.3million times in England in 2010, was included in the full analysis but not calculated separately.
Lead author Dr Daniel Kripke, of the Scripps Clinic, wrote in the British Medical Journal Open: "The meagre benefits of hypnotics [sleeping pills], as critically reviewed by groups without financial interest, would not justify substantial risks.
"A consensus is developing that cognitive-behavioural therapy of chronic insomnia may be more successful than hypnotics."
Sleeping pills, known as hypnotic, are thought to increase depression and can impair driving skills.
Dr Kripke has passed his findings on to the Food and Drug Administration, the watchdog to the pharmaceutical industry in the United States.
Around a third of people in the UK are thought to have bouts of insomnia, and it can become a debilitating problem for some, telegraph reported.
Insomnia tends to be more common in women and is more likely to affect people as they get older.
The authors said their findings, together with similar findings in previous studies, should be used by authorities to re-assess whether even modest doses of sleeping pills are safe.
They estimated the drugs may be linked with between 320,000 and 507,000 deaths in America.
Dr Trish Groves editor of the journal said: "Although the authors have not been able to prove that sleeping pills cause premature death, their analyses have ruled out a wide range of other possible causative factors.
"So these findings raise important concerns and questions about the safety of sedatives and sleeping pills."
NHS guidelines say zolpidem should only be used at the lowest possible dose and for a maximum of up to four weeks.
Zaleplon should only be used at the lowest possible dose and for a maximum of up to two weeks, while temazepam should be taken for a maximum of four weeks.
Nina Barnett Royal Pharmaceutical Society spokesperson on older persons medicines, said: “This is an important study and although it is unlikely to radically change prescribing in the immediate term, it should raise awareness and remind both patients and prescribers to the potential risks of sedative use for insomnia.
"The association between mortality and sedation is not new and this research tells us is that people who took these medicines were more likely to die than people who didn't take them. However it does not mean that the deaths were caused by the medicine.
"Patients should not stop taking any prescribed medicines straight away. If you are concerned about your medicines discuss this with your pharmacist or Doctor about other ways of getting help with sleep problems so you don't have to use medicines."
Malcolm Lader, professor of clinical psychopharmacology at the Institute of Psychiatry at King's College London, said people should not panic as a result of the findings and stop their medication suddenly.
He said patients could suffer epileptic fits or serious withdrawal symptoms if they stopped their medication suddenly.
Professor Lader said the research was a careful study from a well-respected professional but more studies were needed.
"I agree that these drugs do have problems but I find some of these results quite difficult to accept," he said.
"The main one is that with 18 doses a year you have three times the mortality - that's quite incredible because you would have people dropping like flies.
"The study needs to be replicated in a different sample and I think we need to hold judgment until we have further studies.
"What we don't want is people stopping sleeping tablets and then going through a very disturbing period of insomnia.
"People should discuss this with their GP but should not under any circumstances stop taking their medication."


Clic here to read the story from its source.